Current Surgical Management Strategies for Colorectal Cancer Liver Metastases.
associating liver partition and portal vein ligation for staged hepatectomy
colorectal liver metastases
hepatic arterial infusional chemotherapy
liver transplantation
minimally invasive liver resection
one- and two-stage hepatectomy
parenchymal-sparing hepatectomy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
20 Feb 2022
20 Feb 2022
Historique:
received:
25
01
2022
revised:
15
02
2022
accepted:
18
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Colorectal cancer is the third most common cancer diagnosis in the world, and the second most common cause of cancer-related deaths. Despite significant progress in management strategies for colorectal cancer over the last several decades, metastatic disease remains difficult to treat and is often considered incurable. However, for patients with colorectal liver metastases (CRLM), surgical resection offers the best opportunity for survival, can be curative, and remains the gold standard. Unfortunately, surgical treatment options are underutilized. Misperceptions regarding resectable and unresectable CRLM likely play a role in this. The assessment of factors that impact resectability status like medical fitness, technical considerations, and disease biology can be difficult, necessitating careful multidisciplinary input and discussion. The identification of ideal operative time windows that align with the multimodal management of these patients can also be perplexing. For all patients with CRLM it may therefore be advantageous to obtain surgical evaluation at the time of discovering liver metastases to mitigate these challenges and minimize the risk of undertreatment. In this review we summarize current surgical management strategies for CRLM and discuss factors to be considered when determining resectability.
Identifiants
pubmed: 35205811
pii: cancers14041063
doi: 10.3390/cancers14041063
pmc: PMC8870224
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Ann Hepatol. 2010 Apr-Jun;9(2):133-43
pubmed: 20526005
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):711-20
pubmed: 25902703
Ann Surg. 2008 Jan;247(1):125-35
pubmed: 18156932
Ann Surg Oncol. 2021 Dec;28(13):8198-8208
pubmed: 34212254
Curr Opin Organ Transplant. 2021 Apr 1;26(2):139-145
pubmed: 33595983
J Gastrointest Surg. 2010 Nov;14(11):1691-700
pubmed: 20839072
Surg Oncol. 2021 Sep;38:101631
pubmed: 34298267
Arch Surg. 2007 Jun;142(6):526-31; discussion 531-2
pubmed: 17576888
Dan Med J. 2018 Dec;65(12):
pubmed: 30511638
Surg Oncol. 2020 Dec;35:412-417
pubmed: 33035790
HPB (Oxford). 2022 Mar;24(3):299-308
pubmed: 34895829
J Clin Oncol. 2009 Jul 20;27(21):3465-71
pubmed: 19470932
Surg Oncol. 2020 Jun;33:266-269
pubmed: 32561091
Ann Surg Oncol. 2014 Feb;21(2):501-6
pubmed: 24081807
Cancer Treat Rev. 2015 Nov;41(9):729-41
pubmed: 26417845
Lancet Oncol. 2013 Nov;14(12):1208-15
pubmed: 24120480
Eur J Surg Oncol. 2016 Dec;42(12):1798-1805
pubmed: 27260846
Lancet. 2008 Mar 22;371(9617):1007-16
pubmed: 18358928
Eur J Surg Oncol. 2021 Aug;47(8):2038-2045
pubmed: 33640172
Ann Transl Med. 2021 Jan;9(1):7
pubmed: 33553300
Ann Surg Oncol. 2015 May;22(5):1533-9
pubmed: 25323473
Curr Opin Organ Transplant. 2019 Apr;24(2):175-181
pubmed: 30839338
Ann Surg Oncol. 2006 Oct;13(10):1261-8
pubmed: 16947009
Br J Surg. 2014 Apr;101(5):550-7
pubmed: 24756914
Memo. 2017;10(2):103-105
pubmed: 28725278
Cancer Res. 1978 Nov;38(11 Pt 1):3784-92
pubmed: 151583
Ann Surg. 2000 Dec;232(6):777-85
pubmed: 11088072
Surgery. 2018 Jun;163(6):1238-1244
pubmed: 29455841
HPB (Oxford). 2014 Feb;16(2):157-63
pubmed: 23530978
Am J Surg. 2021 Jun;221(6):1114-1118
pubmed: 33722380
Int J Surg. 2018 Apr;52:74-81
pubmed: 29425829
BMC Surg. 2020 Feb 12;20(1):31
pubmed: 32050952
HPB (Oxford). 2007;9(4):251-8
pubmed: 18345300
Ann Surg Oncol. 2016 Feb;23(2):375-81
pubmed: 26561404
Int J Med Robot. 2021 Dec;17(6):e2330
pubmed: 34498805
Biomedicines. 2021 Aug 05;9(8):
pubmed: 34440165
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):933-946
pubmed: 34506756
Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
pubmed: 10493478
JAMA Surg. 2021 Jun 1;156(6):550-557
pubmed: 33787838
Arch Surg. 2007 Dec;142(12):1144-9; discussion 1150
pubmed: 18086980
J Clin Oncol. 2021 Dec 1;39(34):3789-3799
pubmed: 34520230
Br J Surg. 2006 Jul;93(7):872-8
pubmed: 16671066
HPB (Oxford). 2018 Aug;20(8):708-714
pubmed: 29534862
Am Soc Clin Oncol Educ Book. 2021 Mar;41:133-146
pubmed: 34010047
JAMA Surg. 2020 Oct 1;155(10):909-910
pubmed: 32667630
Ann Surg Oncol. 2021 Mar;28(3):1457-1465
pubmed: 33393036
J Clin Oncol. 1984 May;2(5):498-504
pubmed: 6547166
JAMA Surg. 2019 Aug 1;154(8):768-776
pubmed: 31188415
J Surg Oncol. 2010 Aug 1;102(2):125-34
pubmed: 20648582
Ann Surg. 2018 May;267(5):833-840
pubmed: 28902669
Updates Surg. 2021 Jun;73(3):1015-1022
pubmed: 33830484
BMJ. 2021 Sep 15;374:n1855
pubmed: 34526356
Cancer. 1996 Apr 1;77(7):1254-62
pubmed: 8608500
Ann Surg Oncol. 2012 Dec;19(13):4287-99
pubmed: 22766981
Ann Surg Oncol. 2021 Feb;28(2):808-816
pubmed: 32648182
Sci Rep. 2016 Aug 31;6:32304
pubmed: 27577197
J Surg Oncol. 2010 Dec 15;102(8):988-95
pubmed: 21166003
Ann Surg Oncol. 2012 Apr;19(4):1292-301
pubmed: 21922338
JAMA. 2014 May 14;311(18):1863-9
pubmed: 24825641
Cancers (Basel). 2021 Mar 13;13(6):
pubmed: 33805846
J Oncol Pract. 2016 Jan;12(1):40-1
pubmed: 26759465
J Surg Oncol. 2018 Mar;117(4):634-643
pubmed: 29165816
Ann Surg. 2015 Apr;261(4):619-29
pubmed: 25742461
HPB (Oxford). 2012 May;14(5):291-7
pubmed: 22487066
Arch Surg. 2002 Nov;137(11):1305-10
pubmed: 12413326
Dig Surg. 2018;35(4):323-332
pubmed: 29439275
Ann Hepatobiliary Pancreat Surg. 2018 May;22(2):93-100
pubmed: 29896569
J Magn Reson Imaging. 2018 May;47(5):1237-1250
pubmed: 28901685
HPB (Oxford). 2019 Oct;21(10):1411-1418
pubmed: 31078424
Eur J Cancer. 2019 Mar;109:70-83
pubmed: 30690295
Ann Surg. 2006 Aug;244(2):254-9
pubmed: 16858188
Eur J Surg Oncol. 2008 Jun;34(6):609-14
pubmed: 17764887
Medicine (Baltimore). 2020 Feb;99(6):e19029
pubmed: 32028414
Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):299-317
pubmed: 11969240
J Surg Oncol. 2008 Jun 1;97(7):601-4
pubmed: 18449915
Ann Surg. 2016 Jan;263(1):146-52
pubmed: 25775068
Ann Surg. 1997 Dec;226(6):704-11; discussion 711-3
pubmed: 9409569
J Surg Oncol. 2018 Feb;117(2):191-197
pubmed: 28876456
Lancet Reg Health Eur. 2021 Jan 29;3:100049
pubmed: 34557799
J Am Coll Surg. 2010 Jun;210(6):934-41
pubmed: 20510802
Cancers (Basel). 2021 Sep 13;13(18):
pubmed: 34572817
J Clin Oncol. 2008 Nov 1;26(31):5020-1
pubmed: 18794538
BJS Open. 2020 Aug;4(4):685-692
pubmed: 32543788
Ann Surg Oncol. 2015 Jul;22(7):2179-94
pubmed: 25582739
Expert Rev Anticancer Ther. 2017 Aug;17(8):745-758
pubmed: 28636427
J Hematol Oncol. 2019 Feb 14;12(1):16
pubmed: 30764882
HPB (Oxford). 2018 Jul;20(7):631-640
pubmed: 29456199
Ann Surg Oncol. 2015 Jul;22(7):2104-6
pubmed: 25716575
Surg Oncol. 2018 Mar;27(1):A5-A9
pubmed: 29338984
J Clin Med Res. 2019 Aug;11(8):572-582
pubmed: 31413769
Sci Rep. 2020 Feb 6;10(1):1969
pubmed: 32029809
Ann Surg. 2021 Mar 1;273(3):442-448
pubmed: 32049675
Ann Surg. 2006 Jan;243(1):1-7
pubmed: 16371728
J Am Coll Surg. 1998 Dec;187(6):620-5
pubmed: 9849736
J Surg Oncol. 2020 Apr;121(5):848-856
pubmed: 31773747
J Gastrointest Surg. 2000 Mar-Apr;4(2):178-84
pubmed: 10675241
J Clin Oncol. 2006 Aug 20;24(24):3939-45
pubmed: 16921046